Lyme disease: FDA clears new indications for existing tests that may help streamline diagnoses

The U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease. The tests cleared today are the first time that a test has been indicated to follow a new testing paradigm in which two tests called enzyme immunoassays (EIA) are run concurrently ["]

The post Lyme disease: FDA clears new indications for existing tests that may help streamline diagnoses appeared first on Outbreak News Today.